Medicare Enrolled

Dr. Vince Cataldo, MD

Hematology & Oncology · Houston, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1515 HOLCOMBE BLVD, Houston, TX 77030
7137926161
Registered in NPPES since 2006
NPI: 1659393395 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cataldo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cataldo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cataldo

Dr. Vince Cataldo is a hematology & oncology specialist in Houston, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Cataldo performed 793 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Cataldo received a total of $5,619 from 60 pharmaceutical and/or device companies across 284 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cataldo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 793 Medicare services $5,619 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
793
Medicare services
Bottom 43% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
332 $89 $206
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
219 $58 $140
New patient office visit, complex (60-74 min) 82 $157 $343
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
58 $122 $241
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
38 $122 $336
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
38 $91 $172
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
26 $36 $73
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,619
Total received (2018-2024)
Avg $803/year across 7 years
Top 42% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
284
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,974
2023
$2,008
2022
$1,443
2021
$31
2020
$15
2019
$123
2018
$26

Payments by company (2024)

PFIZER INC.
$214
AstraZeneca Pharmaceuticals LP
$151
Daiichi Sankyo Inc.
$129
Merck Sharp & Dohme LLC
$128
Novartis Pharmaceuticals Corporation
$103
ABBVIE INC.
$97
Pharmacosmos Therapeutics Inc.
$88
Eisai Inc.
$84
Alexion Pharmaceuticals, Inc.
$72
Celgene Corporation
$65
E.R. Squibb & Sons, L.L.C.
$64
PharmaEssentia USA Corporation
$58
Karyopharm Therapeutics Inc.
$57
Ipsen Biopharmaceuticals, Inc
$55
BeiGene USA, Inc.
$55
Genentech USA, Inc.
$52
Incyte Corporation
$50
GENZYME CORPORATION
$49
Regeneron Healthcare Solutions, Inc.
$46
Janssen Biotech, Inc.
$42
JAZZ PHARMACEUTICALS INC.
$40
Takeda Pharmaceuticals U.S.A., Inc.
$36
SpringWorks Therapeutics, Inc.
$35
Blueprint Medicines Corporation
$23
ARRAY BIOPHARMA INC
$20
GlaxoSmithKline, LLC.
$20
Tempus AI, Inc
$19
Azurity Pharmaceuticals, Inc.
$18
SERVIER PHARMACEUTICALS LLC
$17
TAIHO ONCOLOGY, INC.
$17
Alnylam Pharmaceuticals Inc.
$15
Myriad Genetic Laboratories, Inc.
$14
MorphoSys, US Inc.
$14
Spectrum Pharmaceuticals Inc.
$14
Kite Pharma, Inc.
$14
Top 3 companies account for 25.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$435
PFIZER INC.
$366
Merck Sharp & Dohme LLC
$343
GENZYME CORPORATION
$285
Celgene Corporation
$265
AstraZeneca Pharmaceuticals LP
$259
Alexion Pharmaceuticals, Inc.
$245
Daiichi Sankyo Inc.
$224
Eisai Inc.
$218
Genentech USA, Inc.
$218
E.R. Squibb & Sons, L.L.C.
$207
Myriad Genetic Laboratories, Inc.
$188
Pharmacosmos Therapeutics Inc.
$168
Janssen Biotech, Inc.
$160
Incyte Corporation
$118
Karyopharm Therapeutics Inc.
$116
Ipsen Biopharmaceuticals, Inc
$115
BeiGene USA, Inc.
$108
Pharmacyclics LLC, an AbbVie Company
$104
ABBVIE INC.
$97
Gilead Sciences, Inc.
$89
Takeda Pharmaceuticals U.S.A., Inc.
$88
JAZZ PHARMACEUTICALS INC.
$81
Blueprint Medicines Corporation
$79
Stemline Therapeutics Inc.
$69
Lilly USA, LLC
$65
MorphoSys, US Inc.
$65
Amgen Inc.
$60
PharmaEssentia USA Corporation
$58
Bayer Healthcare Pharmaceuticals Inc.
$53
G1 Therapeutics, Inc.
$49
Regeneron Healthcare Solutions, Inc.
$46
Seagen Inc.
$45
CTI BioPharma Corp.
$35
SpringWorks Therapeutics, Inc.
$35
Progenics Pharmaceuticals, Inc.
$30
Alnylam Pharmaceuticals Inc.
$29
Astellas Pharma US Inc
$25
Exelixis Inc.
$23
Grifols USA, LLC
$22
Sobi, Inc
$21
Mirati Therapeutics, Inc.
$21
ARRAY BIOPHARMA INC
$20
GlaxoSmithKline, LLC.
$20
Taiho Oncology, Inc.
$19
Tempus AI, Inc
$19
Azurity Pharmaceuticals, Inc.
$18
SERVIER PHARMACEUTICALS LLC
$17
TAIHO ONCOLOGY, INC.
$17
Veracyte, Inc.
$17
Genmab U.S., Inc.
$17
Pharmacyclics LLC, An AbbVie Company
$16
Coherus Biosciences Inc.
$15
Tactile Systems Technology Inc
$15
Puma Biotechnology, Inc.
$15
EMD Serono, Inc.
$15
Spectrum Pharmaceuticals Inc.
$14
Kite Pharma, Inc.
$14
Seattle Genetics, Inc.
$12
EISAI INC.
$12
Top 3 companies account for 20.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · Alecensa · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · COSELA · Columvi · DARZALEX · DOPTELET · ELREXFIO · ENHERTU · ENJAYMO · EPKINLY · Enhertu · Flexitouch Plus · GAZYVA · GIVLAARI · Gamunex-C · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NINLARO · Nplate · Nubeqa · OGSIVEO · ONUREG · OPDIVO · OPDUALAG · Onivyde · Orserdu · PIQRAY · PLUVICTO · PRECISETUMOR · PROMACTA · PYLARIFY · Phesgo · Pomalyst · REBLOZYL · ROLVEDON · Revlimid · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · Stivarga · TASIGNA · TECVAYLI · TUKYSA · Tecentriq · Tibsovo · Tivdak · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VIVIMUSTA · Vonjo · WELIREG · XPOVIO · XTANDI · Xtandi · Yescarta · ZEPZELCA · myChoice CDx
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Houston?
Compare hematology & oncology specialists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
202
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Cataldo is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Cataldo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Cataldo performed 332 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Cataldo receive payments from pharmaceutical companies?
Yes. Dr. Cataldo received a total of $5,619 from 60 companies across 284 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cataldo's costs compare to other hematology & oncology specialists in Houston?
Dr. Cataldo's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cataldo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →